Resources Contact Us Home
Modified leukotoxin protein

Image Number 15 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Color image display device, color filter substrate, color pixel array substrate, and electronic device
Breathing mask
HYR1 as a target for active and passive immunization against Candida
Matching engine for comparing data feeds with user profile criteria
Resistor-2 resistor (R-2R) digital-to-analog converter with resistor network reversal
Conductor-mixed active electrode material, electrode structure, rechargeable battery, and manufacturing method of conductor-mixed active electrode material
Secure access to customer log data in a multi-tenant environment
  Randomly Featured Patents
Exercising device and method of using same
Methods, compositions and apparatus for cleaning surfaces
Data deduplication dictionary system
Toy telephone with integral lollipop holder
Tank content gauging system
Electronic component with a stack of semiconductor chips and a method for producing the electronic component
Front of a drawer
Active optical connector including an electronic circuit board and an optical fiber
3-Alkoxy-4-substituted-phenoxy-2,3-unsaturated acids, esters and derivatives
Dielectric ceramic compositions and dielectric resonators